Press release
ADP Nominates Karen S. Lynch and Robert H. Swan to Board of Directors
ROSELAND, N.J., Sept. 25, 2025 /PRNewswire/ -- ADP (Nasdaq: ADP), a global leader in HR and payroll solutions, announced today that Karen S. Lynch and Robert
About this update from Automatic Data Processing, Inc.
[{"type":"text","content":"ROSELAND, N.J., Sept. 25, 2025 /PRNewswire/ -- ADP (Nasdaq: ADP), a global leader in HR and payroll solutions, announced today that Karen S. Lynch and Robert H. Swan have been nominated to the Board of Directors in connection with ADP's Annual Meeting of Stockholders, set for November 12, 2025. \nKaren S. Lynch is a recognized leader with over three decades of experience operating within the highly regulated and complex health care industry. She served as President and Chief Executive Officer of CVS Health Corporation, a leading health solutions company, from 2021 to 2024. \nRobert H. Swan has extensive global operational, financial and business expertise as a former CEO and CFO of large public technology companies. He has been an Operating Partner at Andreessen Horowitz since July 2021. \n\"We are delighted to nominate each of Karen and Bob to the ADP Board,\" said Thomas J. Lynch, independent non-executive chair of the Board for ADP. \"With their wealth of broad-based experiences, they each bring a unique blend of strategic, operational and financial expertise that will be invaluable to ADP as the company executes on its three strategic priorities.\"\n\"New technologies and shifting workplace dynamics continuously reshape the way people work,\" said Maria Black, president and chief executive officer of ADP. \"We're thrilled that Karen and Bob have been nominated to the ADP Board as we continue our focus on providing our clients with HCM technology that is easy to use, powered with smart insights and personalized to support a human-centric experience.\" \nBefore becoming President and CEO of CVS Health Corporation, Ms. Lynch served as Executive Vice President of CVS Health Corporation from 2018 to 2021. From 2015 to 2021, she was the President of Aetna, which CVS Health acquired in 2018. Ms. Lynch began her career as a Certified Public Accountant at auditing firm Ernst & Young LLP. She is currently a director of Thermo Fisher Scientific Inc. and holds a Bachelor of Science from Boston College and a Master of Business Administration from Boston University.\nBefore joining Andreessen Horowitz, Mr. Swan served at Intel Corporation as CEO from February 2019 to February 2021, as Interim CEO and CFO from June 2018 to January 2019 and as CFO from October 2016 to June 2018. Prior to joining Intel, he held several senior management role...